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Abstract
The mammalian postsynaptic density (PSD) comprises a complex collection of ~1100 proteins.
Despite extensive knowledge of individual proteins, the overall organization of the PSD is poorly
understood. Here, we define maps of molecular circuitry within the PSD based on phosphorylation
of postsynaptic proteins. Activation of a single neurotransmitter receptor, the N-methyl-D-aspartate
receptor (NMDAR), changed the phosphorylation status of 127 proteins. Stimulation of ionotropic
and metabotropic glutamate receptors and dopamine receptors activated overlapping networks
with distinct combinatorial phosphorylation signatures. Using peptide array technology, we
identified specific phosphorylation motifs and switching mechanisms responsible for the
integration of neurotransmitter receptor pathways and their coordination of multiple substrates in
these networks. These combinatorial networks confer high information processing capacity and
functional diversity on synapses and their elucidation may provide new insights into disease
mechanisms and new opportunities for drug discovery.
INTRODUCTION
The vertebrate PSD, the specialized region at which one neuron receives electrical input
from another, is strikingly complex, consisting of over 1000 proteins. Understanding the
functional architecture of the molecular networks formed by these synaptic proteins is
critical to understanding how neurons transmit and process information.
Excitatory synapses of the mammalian hippocampus exhibit structural and functional
plasticity thought to underlie the processes of learning, memory, and various behaviors (1).
The N-methyl-D-aspartate–type glutamate receptor (NMDAR) participates in complexes
with scaffold proteins and various other molecules (2–5). Activation of NMDARs is known
to modulate the activity of postsynaptic tyrosine, serine, and threonine kinases (1, 6), and it
has become increasingly clear that hundreds of phosphorylation sites on many classes of
proteins exist (1, 7–9). Although it is not known whether these phosphorylation sites are
organized into signaling networks of many highly interconnected proteins, computational
models support the view that synaptic signaling networks are advantageous over traditional
simpler biochemical models that utilize few molecular steps in simple pathways (10, 11).
These advantages include improved storage and retention of memories (12, 13). Although
recent studies have modeled synapse proteome interaction networks in the postsynaptic
terminal (14, 15) and cannabinoid receptor–driven neuronal transcription factor networks
(16), the signaling networks in the PSD are poorly defined.
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Here, we report the mapping of postsynaptic phosphoproteome signaling networks with the
use of a combination of in vivo, in vitro, and computational approaches. These
phosphoproteome networks show that a single neurotransmitter receptor integrates hundreds
of downstream postsynaptic events into a network that overlaps with those driven by other
neurotransmitter receptors. The networks show multiple levels of organization and contain
building blocks of components that assemble the molecular circuitry of synapse signaling.
This organization into molecular circuits has important implications for the basic
mechanisms of learning and disease and its elucidation opens new avenues for drug
discovery in the brain.
RESULTS
Neurotransmitter receptors drive overlapping postsynaptic proteome networks that
modulate protein phosphorylation status
The NMDAR was stimulated in mouse hippocampus brain slices by bath application of
NMDA, a protocol that induces long-term depression (LTD) (17). The phosphorylation of
PSD proteins was quantified by liquid chromatography–tandem mass spectrometry (LC-MS/
MS). Three minutes of exposure to NMDA elicited changes in the phosphorylation status of
127 proteins (Fig. 1A) and 189 phosphopeptides (tables S1–S3); the phosphorylation of
41phosphorylated peptides showed no significant change. Phosphorylation increased on 44
peptides (23%) from 38 proteins (28%) and decreased on 145 (77%) peptides from 101
proteins (79%) indicating the simultaneous regulation of kinases and phosphatases These
substrate proteins were members of a wide range of functional classes: Channels and
receptors accounted for 10% of all modulated proteins; these included some implicated in
fast synaptic transmission [e.g., the GluR2 subunit of the ionotropic AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid) receptor] and excitability (e.g., voltage-gated
K+ channels) and some implicated in slower processing pathways (e.g., Ca2+ channels and
the metabotropic G protein–coupled glutamate receptor 5, mGluR5). Structural components
(scaffolding proteins, cytoskeletal proteins, and proteins involved in cell adhesion)
accounted for 30% of all modulated proteins, whereas proteins implicated in transcription
and translation accounted for ~15%. This last group was largely split between proteins
mediating pre–messenger RNA splicing (60%) and transcription (33%). These data indicate
that NMDAR stimulation activates a signaling network that modulates the phosphorylation
status of >100 postsynaptic proteins, thereby influencing diverse functional processes.
Of 540 members of the total mouse kinome (18), ~50 kinases are found in the PSD (4, 19,
20). We measured the NMDAR-dependent activation of 23 PSD kinases (Fig. 1, B and C) at
3, 20, and 40 min after NMDA application, using immunoblotting with phosphospecific
antibodies. Nine PSD kinases (39% of those tested) showed changes in phosphorylation
status, with 7 showing increased phosphorylation and 2 showing decreased phosphorylation.
The peak change was detected at 3 min after NMDA treatment and phosphorylation status
had returned to baseline by 40 min. The 9 modulated kinases included representatives of
four major kinase groups: AGC (protein kinase A, protein kinase G, and protein kinase C,
PKA-PKG-PKC), CMGC [cyclin-dependent kinases (CDKs), mitogen-activated protein
kinases (MAPKs), glycogen synthesis kinases (GSKs), and CDK-like kinases], STE (sterile-
phenotype kinases), and PTK (protein tyrosine kinase). Together with the MS data, these
indicate that NMDAR activation simultaneously modulates the activity of multiple kinases
(in various classes), leading to changes in the phosphorylation status of numerous substrates.
Metabotropic glutamate receptors (mGluRs) and dopamine receptors physically interact with
NMDAR in postsynaptic complexes, and their activation also modulates synaptic plasticity
and behavior. Using phosphospecific antibodies, we treated hippocampal slices with specific
receptor agonists [NMDA to activate NMDAR, 3,5-dihydroxyphenylglycine (DHPG) to
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activate mGluR, and the dopamine receptor D1 agonist 6-chloro-7,8-dihydroxy-1-
phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (6-Cl-PB)], extracted proteins, and assessed
phosphorylation of 10 sites on four glutamate receptor subunits (Fig. 2 and table S4).
Stimulation of these receptors elicited distinct but overlapping changes in the
phosphorylation status of these 10 sites. Similarly, activation of dopamine and glutamate
receptors, treatments that are known to stimulate PKA and PKC activity (23, 24), produced
overlapping profiles in the 10 sites, showing further combinations in the postsynaptic
phosphorylation network.
Because these neurotransmitter receptors are the targets for therapeutic drugs, our results
open the possibility that the phosphorylation networks they activate may include disease-
relevant proteins. Of the NMDA-modulated proteins, 21 are implicated in the pathology of
Alzheimer’s (AD), Parkinson’s, and Huntington’s diseases, schizophrenia, or autism (table
S5). Moreover, reflecting the overlap in their corresponding networks, drugs that modulate
NMDA receptor, mGluR, or dopamine receptor function are useful in treating the symptoms
of this set of diseases (21–28).
Phosphoproteome building blocks
In its simplest form, the addition or removal of a phosphate residue is a fundamental binary
switch that changes the properties of a protein (29). To understand how a signaling network
is organized, it is necessary to build a phosphoproteome network that includes information
on the kinases that phosphorylate specific sites. We classified a set of “minimal building
blocks” representing fundamental regulatory motifs (analogous to types of switches) that can
be assembled to produce a molecular circuitry of the postsynaptic proteome (Fig. 3, A to G).
This set of regulatory motifs represents both phosphorylation events that occur on single
phosphorylation sites (Fig. 3A) and those that involve multiple phosphorylation sites (where
the phosphoacceptors are within 10 amino acid residues) (Fig. 3B). Of 610 known in vivo
phosphorylation sites present in 92 synaptic proteins (7), 383 (63%) occurred within 10
amino acids of another, indicating that both types of sites are common (tables S6, S7, and
S8). Considering single-site substrates, a single kinase may phosphorylate multiple
independent sites (kinase divergence motif; Fig. 3C) or multiple kinases can phosphorylate a
common site (kinase convergence motif; Fig. 3D). Considering two adjacent-site substrates
(as the simplest version of multiple sites), each site can be independently phosphorylated
(paired convergence motif, Fig. 3, E and F) or priming or interference between pairs can
occur when the phosphorylation of the first site in the pair influences the phosphorylation of
the second site (primed convergence motif; Fig. 3G).
To map the distribution of these building blocks onto known phosphorylation sites in the
postsynaptic proteome, we constructed peptide arrays comprising these sites and assayed
phosphorylation by specific kinases. A postsynaptic phosphoproteome array (PPParray),
with 600 peptides corresponding to 300 in vivo phosphorylation sites on 92 synaptic
proteins, was constructed from in vivo phosphorylation sites modulated by NMDA, large-
scale synapse phosphoproteomic studies (7), or individual publications (tables S6, S9, and
S10). Peptides were immobilized on glass slides, together with their corresponding control
(in which the serine, threonine, or tyrosine phosphoacceptor sites were substituted with
alanine, valine, or phenylalanine, respectively) (Fig. 3H). Positive control peptides
containing consensus sequences for specific kinases were included. The classes of proteins
represented included receptors, scaffolding proteins, enzymes, cytoskeletal proteins, and
others.
Twenty-five postsynaptic kinases (table S11) with representatives from all major families in
the mouse kinome were used to phosphorylate the PPParray (Fig. 3H). Phosphorylation was
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regarded as positive if reproduced in triplicate and detected above background of negative
controls (table S12). A total of 723 phosphorylation events (kinase phosphorylation of a site)
were detected, involving all 25 kinases and 77 (84%) of the 92 proteins. Of the 300 sites
assayed, 166 (55%) were phosphorylated (471 events) (table S13). We also detected the
phosphorylation of 36 other specific sites (94 events), of which 30 were previously
undescribed in vitro sites (table S7). A further 158 events on 58 sequences where the
specific site could not be unambiguously determined (because there were 2 or more potential
phosphoacceptor sites) were also detected (table S14). We created a Web resource that
provides access to these data and provides links to physiological and behavioral data from
knockout mice as well as disease data for the respective kinases and substrates
(www.genes2cognition.org/phosphoproteomics/coba1/).
All kinases and substrates studied were localized in the PSD and we further examined the
kinase-site assignment in vivo. In addition to our experiments with phosphospecific
antibodies and kinase manipulations in hippocampal slices (described below), we mined the
literature for relevant data. Overall, of the 166 sites phosphorylated by 25 kinases in the
PPParray, we found in vivo validation for 78 (47%) sites by 14 (56%) kinases (tables S6 and
S8). We extended these validation data with additional experiments testing the kinase
assignments to specific sites on key synaptic proteins implicated in synaptic plasticity:
kinases; ERK2 (extracellular signal–regulated kinase 2) (30), PKA (31), GSK3 (32), and
CaMKII (calcium- and calmodulin-dependent protein kinase) (33); substrates for
phosphorylation—PSD95 (34), the NR2B subunit of the NMDR (35), and GluR1 (36).
These examples indicate that the assignment of kinases to known in vivo sites (discovered
using MS) using peptide arrays provides reliable validation of kinase-substrate
identifications (fig. S1). Furthermore, in vivo data from other laboratories provided
additional prospective validation of novel PPParray assignments during the course of our
experiments, tyrosine phosphorylation of NR2B Tyr1304;Calpain-1 site Tyr387
(www.phosphosite.org), and GluR1 Thr840 (37)(Thr858 in (8, 37) were described in vivo
following their in vitro discovery.
Postsynaptic phosphoproteome networks
Figure 4, which shows the kinase-substrate network with annotations of functional classes
and regulatory motifs, illustrates the complexity ofsynaptic phosphorylation and widespread
distribution of switching mechanisms. Note that this diagram underrepresents the scale of
phosphorylation because individual sites are not shown within the substrates. Moreover, this
network would be expected to increase in density if further postsynaptic kinases and
substrates were tested. We therefore consider this a draft map of the synapse
phosphoproteome network that allows us to identify general principles of its organization
and function.
We next examined the distribution of phosphorylation events (Fig. 5A). Individual serine,
threonine, or tyrosine kinases phosphorylated between 5 and 56 sites, with an average of 29
sites per kinase (a pattern characterized as the kinase divergence motif; Fig. 3C). These
phosphorylation sites were distributed over 4 to 36 protein substrates, with an average of 21
substrates phosphorylated by a single kinase. To investigate the range of cell biological
processes influenced by each kinase, substrates were assigned to broad functional families,
including ion channels and receptors, scaffolding proteins, cytoskeletal proteins, and others
(table S9). The substrates of a kinase were typically drawn from a wide range of families.
For instance, PKA phosphorylated 29 substrates from 9 families and ERK2 phosphorylated
36 substrates from 8 families. Phosphoinositide-dependent kinase–1 (PDK-1, known
primarily as a regulator of kinases) had the most restricted range, phosphorylating 4
substrates from 4 functional families.
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We next examined the convergence of multiple kinases onto single sites (kinase
convergence motif; Fig. 3D), which allows both redundancy and regulation by multiple
ranges of upstream pathways. We found 66 (86%) of the 77 substrates and 129 (64%) of the
202 specific sites phosphorylated in the array were phosphorylated by more than one kinase
(tables S7, S13, and S14). Although the majority of sites targeted by multiple kinases were
phosphorylated by 2 to 5 kinases, a small number of “hub” sites were phosphorylated by 8 to
12 kinases (Fig. 5C). At the protein level, a set of highly phosphorylated substrates (hub
substrates) that interacted with 10 or more kinases could also be identified (Fig. 5C). For
example, the adaptor protein, insulin receptor substrate 1 (IRS1), a critical node in insulin
signaling and cross talk point of different signaling cascades, was phosphorylated 58 times
by 23 kinases with Ser24 phosphorylated by 9 kinases. These hubs, which are potentially key
points of convergence between multiple signaling pathways, were distributed relatively
evenly between functional classes of substrates. Thus, kinase convergence of multiple
kinases upon a single site appears to be widespread in the postsynaptic proteome.
Although kinase families phosphorylated a large range of substrates, clustering proteins
based on the density of kinase-substrate interactions indicated a broad pattern of
organization. When the kinases were grouped according to their generic site or motif
specificity (38) into tyrosine (Tyr), proline-directed (Pro), basophilic (Bas), acidophilic or
phosphate-directed (Ac/Ph), and Other kinases (Fig. 5, A and B), the network was found to
be composed of three modules enriched with Bas, Pro, and Tyr kinases, respectively. At the
level of individual sites, channels and receptors predominated among targets of Bas kinases,
whereas cytoskeletal proteins were most frequently phosphorylation targets of Pro kinases
(Fig. 5A). Among multiply phosphorylated Ser/Thr sites, 71% (67 of 95) primarily
interacted (>50% of interactions) with one kinase class. For example, glutamate receptor
sites accounted for 30% of all sites primarily phosphorylated by Bas kinases (P = 0.0002)
and none of the sites in G proteins and modulators were primarily phosphorylated by Pro
kinases (P = 0.007).
The above observations concerning Ser/Thr kinases would appear to reflect the sequential
organization of second messenger pathways coupled to neurotransmitter receptors. Many
Bas kinases (such as CaMKII, PKA and PKC) are regulated by second messengers and can
be thought of as lying at the top of kinase cascades, converting Ca2+,adenosine 3′,5′-
monophosphate (cAMP) and other signals into changes in phosphorylation. Downstream
components of cascades such as the ERK/MAPK pathway are typically Pro-directed and
“Other” Ser/Thr kinases. Our observations suggest that feedback control of pathway
activation (channels and receptors) is largely due to upstream (Bas) kinases, whereas
downstream kinases primarily coordinate output changes in cell-biological processes
underlying plasticity (for instance cytoskeletal organization).
At the synapse these relationships may be modulated by proteinprotein interactions, which
organize kinases and their substrates into complex signaling units such as the NMDAR
complex (NRC) of MASC (membrane-associated guanylate kinase associated signaling
complex). Within the NRC/MASC interaction network (15), Bas kinases were on average
2.5 steps from the nearest receptor subunit, significantly closer than Pro-directed/Other Ser/
Thr kinases, which were on average 3.6 steps from a receptor (Welch two-sample t test, P =
0.026). Thus, the sequential organization into upstream (Bas) and downstream Ser/Thr
kinases appears to be reinforced by protein-protein interactions within neurotransmitter
receptor complexes.
Additional patterns were observed at the level of convergence of kinase classes onto
adjacent phosphorylation sites (paired convergence motif; Fig. 3E). Individual sites were
first classified according to the type of kinase providing their major source of interactions
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(for instance, Pro, Tyr), with those for which no single type provided more than 50% of
interactions being classified as “mixed.” The frequency with which pairs of classes occurred
as adjacent sites was then compared to a random distribution. Same-class pairings were
significantly enriched, notably Pro-Pro (P <10 −4), Ac/Ph-Ac/Ph (P = 0.003) and Bas-Bas (P
= 0.01). So not only do kinases from the same class converge on a similar set of substrates,
they also converge onto adjacent sites within those substrates, allowing within-class
modulation.
Bas kinases, the primary target for synaptic second messengers, also appeared to play a
major role in between-class convergence onto adjacent sites, because Pro-Tyr (P = 0.01) and
Pro-Ac/Ph (P = 0.02) pairings were significantly underrepresented. Thus, pairing of adjacent
sites allows coordination within the functional units defined by kinase classes, and facilitates
feed-forward regulation (through Bas kinases) by second messengers.
Multiphosphorylation site switches
Previous studies of multiply phosphorylated sequences have uncovered interactions between
sites with the presence of a phosphate on one site influencing the probability of
phosphorylation at another (primed convergence motif; Fig. 3G) (39, 40). For example,
enhancement of GSK3β phosphorylation has been widely described, with several kinases
being reported to prime GSK3β activity. These include cyclin-dependent kinase 5 (CDK5)
that primes GSK3β to phosphorylate Tau and collapsin responsive mediator protein–2
(CRMP2) (41, 42); PKA primes GSK3β to phosphorylate Tau (43); dual-specificity
tyrosine-phosphorylated and regulated kinases (DYRK) prime GSK3β to phosphorylate
eIF2Bε (44); and GSK3β primes itself to phosphorylate CRMP2 (45). Inhibitory
interactions have also been reported; for instance, increased phosphorylation of IRS1 Tyr608
after insulin receptor stimulation correlates with decreased in vivo phosphorylation of IRS1
S612 by MAPK (46).
It is not clear whether primed convergence is restricted to a few key proteins or is
widespread. We designed a second set of arrays in which 200 sequences from multiple
phosphorylated sequences were tested with seven different synaptic kinases (Fig. 6A and
tables S15 and S16). For these analyses, we substituted serines, threonines, or tyrosines by
their phosphorylated analogs in different combinations. Thus, we were able to quantify the
level of phosphorylation of a particular site when an adjacent residue was phosphorylated.
Control peptides (in which Ser, Thr, and Tyr were substituted for Ala, Val, and Phe,
respectively) were also included. We found that the presence of a phosphorylated site altered
the phosphorylation in 66% of neighboring sites. Of these “primed” sites, 73% were
inhibitory and 27% were enhancing (Fig. 6, B to D) and found in multiple classes of
proteins. Amongst these sites, we observed specific examples supported by the literature,
such as priming of GSK3β (40). These switching and priming events can act as molecular
“coincidence detectors” and are widespread in the postsynaptic proteome.
Widespread regulation of protein interaction domains
To explore the extent of phosphorylation-dependent protein interactions, we exploited the
site-specificity information on protein interaction domains revealed in our NMDA
stimulation data sets. Overall, 81 (65%) NMDA-modulated proteins contained potential sites
within binding ligand motifs (the sequences that bind protein interaction domains). The
binding domain ligands predominantly regulated by NMDA stimulation were WW4 (P <
0.0001), Src homology 3 (SH3) type III (P = 0.0025), SH2 STAT5 (P = 0.04), and MYND
(myeloid, Nervy, and DEAF-1) (P = 0.04) (fig. 2A). Cytoskeletal proteins harbored 42% of
phosphopeptides containing WW motifs and 47% with SH3 motifs (both associated with
proline-directed kinases) (P = 0.00001 and 0.007, respectively). Transcription and
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Translation proteins harbored 35% of peptides with 14-3-3 motifs (P = 0.001); and
MAGUKs, Adaptors, and Scaffold harbored 25% of peptides with FHA (forkhead-
associated) motifs (P = 0.02). Moreover, there was a close correspondence between
individual kinase classes and the types of binding interaction that they regulate. Taking the
set of PPParray sites within binding domain ligand motifs, we found that 70% of Ser/Thr
sites in SH3 motifs and 50% in WW motifs were primarily phosphorylated by Pro kinases (P
= 0.0001 and P = 0.005, respectively). Fifty percent of Ser/Thr sites in FHA motifs were
unique to Ac/Ph kinases (P =0.008)and 55% Ser/Thr sites in 14-3-3 motifs were unique to
Bas kinases (P = 0.01). Seventy percent of all Tyr sites were found in SH2 motifs (P =
0.00005). Reflecting the abundance of cytoskeletal proteins among substrates of Pro kinases,
SH3 ligand motifs overlapping phosphorylated sites were present in 60% of cytoskeletal
proteins studied in the array (P = 0.004). These data indicate that phosphorylation-dependent
regulation of protein-protein interactions is widespread with different kinase classes
modulating different subsets of interactions and reshaping the PSD.
DISCUSSION
Dynamic PSD phosphoproteome networks
Using large-scale proteomic approaches, we find that neurotransmitter receptors initiate
signaling in overlapping networks of hundreds of phosphorylation sites on more than 100
postsynaptic proteins. We identified multiple levels of network organization constructed
from a set of phosphorylation motifs or building blocks that define wiring of the network.
This organization included regulatory switches for enhancing and inhibiting signaling as
well as hubs and signal convergence points. Multiple disease proteins mapped onto these
signaling networks, which are modulated by therapeutic drugs that engage receptors driving
these networks. The postsynaptic proteome networks provide a fresh view of the molecular
complexity of synapse function that reveals an elaborate circuitry built on simple motifs
with combinatorial and computational features.
What property does this computational machinery provide and why do synapses require
such elaborate molecular circuitry? These networks provide a framework for the
transmission of information from a single neurotransmitter receptor to numerous “output”
proteins (receptors, channels, structural, translational regulation, signaling). Second, the
network allows these sets of proteins to be orchestrated. Third, multiple kinases and
convergence mechanisms provides robustness and resilience to perturbation of a single node
in the network, such as a specific kinase, site, or substrate (47). Fourth, the priming seen
within multiple phosphorylated sites allows coincidence detection and switching. For
example, NMDAR-mediated phosphorylation of site 1 in a pair of sites may interfere or
enhance the ability of site 2 to be phosphorylated by a kinase driven by the dopamine
receptor. In addition to modulating specific substrates, these priming switches may control
specific subnetworks of functional proteins (with different physiological outcomes). Other
network mechanisms include feedback (for instance, kinase auto- and transphosphorylation)
and forms of regulatory cross talk. These mechanisms allow receptors individually, in
combination, or in different temporal sequences to activate overlapping networks that
orchestrate and differentially regulate a combination of effector substrates, which modulate
many properties of the nerve cell and produce a range of physiological outcomes.
Network regulation of synaptic plasticity
Mutations or pharmacological perturbations show that many synaptic proteins are required
for induction of long-term potentiation (LTP) of synaptic transmission (5, 15, 48-53)
(www.genes2cognition.org/db) (54). These LTP proteins are found in a wide range of
functional classes including receptors, scaffolding proteins, enzymes, cytoskeletal proteins,
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and transcriptional regulators, among others. Our data link together these molecules into a
functional signaling network and provides a framework for understanding their
interrelationships.
The large repertoire of phosphorylation sites presents potential for combinatorial patterns of
phosphorylation. Using stimulation conditions that activate different kinase pathways, we
observed distinct combinations of phosphorylation patterns on multiple substrates (10 sites
on four proteins) and unique combinations within a single protein (GluR1 S831, T840,
S845) (table S16). This indicates that the presence of a phosphate on one site does not
necessarily correlate with the physiological state of the synapse (e.g., LTP or LTD) and that
a combinatorial code of sites is likely more relevant. This is supported by data on GluR1
phosphorylation where increases in phosphorylation of Ser845 and of Ser831 correlate with
either LTP or LTD (55–57). An advantage of this combinatorial phosphorylation code is that
an enormous number (>2100) of possible physiological states could arise from the network,
although our findings indicate that the number of distinct combinations that occur will be
constrained.
Specific combinations of phosphorylation are likely to map onto short-term (~minutes) and
long-term (hours) processes that confer precise tuning of synaptic physiology and its
metaplasticity (58, 59). For example, three types (N, L, and R) of calcium channel, each
with differing kinetics, were modulated by NMDAR (table S15) along with other channels
that influence synaptic currents. Another postsynaptic kinase-dependent mechanism of long-
term maintenance of LTP involves the synthesis of PKMζ (the active form of PKCζ),
postulated as a site of convergence and integration for multiple kinases (60). The role of
PKMζ in LTP maintenance has been well described (61); however, its targets remain
elusive. Our peptide arrays showed that PKCζ phosphorylated 25 different substrates among
different functional classes, including glutamate receptor subunits (NR1, GluR1, GluR2,
mGluR4a, mGluR7a), scaffold proteins (PSD-95), kinases (PKC-ι), phosphatases, (PP1C-
A), and others (tables S6 to S8), which together may regulate LTP maintenance. We also
found proteins not previously implicated in plasticity, including several splicing factors
(table S15), which is of interest because recent evidence suggests a role for localized
splicing in dendrites (62).
Implications for learning and memory
The electrophysiological paradigm of LTP, which is the prevailing model for learning and
memory, is based on synapses shifting between a weak and a strongstate (63, 64).
Computational models, however, indicate that simple two-state synapses are poor at storing
memories and vulnerable to erasure (12, 13). Using models in which synapses exist in a
higher number of physiological states, Fusi and Abbott found improved memory
performance with even a few additional states (they chose 15) (13). Our multistate
phosphoproteome networks could provide such states and, thus, improved memory
performance. Our data are also compatible with known molecular mechanisms of
metaplasticity, the “plasticity of synaptic plasticity” (58, 59). Metaplasticity models
introduce additional functional states and transitions between them. For example, the ability
of a synapse to strengthen or weaken is influenced not only by the immediate activity that
induces LTP or LTD, but also by its prior history of activity. Kinases and phosphatases and
the receptors that activate postsynaptic networks are known to regulate metaplasticity. These
physiological models of metaplasticity have identified relatively few forms of synaptic
plasticity (<20) (65) compared with postsynaptic phosphoproteome states. Future modeling
studies could consider the far higher numbers of states of molecular networks as well as the
role of subnetworks with distinct properties.
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We propose that a single synapse exploits the molecular complexity of postsynaptic
proteomes to represent and process a wide range of information states reflecting the
incoming information from neurotransmitters as well as the prior history (memory) of the
synapse. The outcome is to change the states of the molecular network across a vast range,
represented in the combinations of phosphorylation. These multistate networks could
provide the multistate mechanisms that were shown to confer improved memory storage and
recall over simpler synapse models (12, 13)
Synapse phosphoproteome networks and disease
These network mechanisms of learning and plasticity raise the possibility that network
disruption may arise in diseases of cognition. Of the NMDA-modulated proteins identified
in our study, 21 have been implicated in various disorders, including AD, Huntington’s and
Parkinson’s disease, schizophrenia, and autism (table S17). The role of phosphorylation in
AD illustrates many of the network regulatory features identified earlier. AD is a common
neurodegenerative disorder characterized by the presence of extracellular amyloid plaques
and intracellular neurofibrillary tangles largely composed of hyperphosphorylated
microtubule-associated protein tau. Of the NMDA-modulated proteins implicated in AD
(CRMP2, GSK3β, Map1b, Map2, tau, Ndrg2, P140, Itsn1), most are involved in
microtubule/ cytoskeletal dynamics. CRMP2 regulates microtubule formation by binding
tubulin. This interaction is regulated by GSK3β phosphorylation of CRMP2 at Thr509/
Thr514/Ser518, subject to priming by Cdk5 at Ser522 (42). Cdk5 also primes GSK3β
phosphorylation of tau (66). Consistent with this, we found NMDAR stimulation increased
inhibitory phosphorylation of GSK3β and led to the dephosphorylation of CRMP2 peptides
containing Thr514 and Ser518 (and also Ser522). Hyperphosphorylation of CRMP2 at
Thr509,Thr514,Ser518,and Ser522 is present in AD, preceding the appearance of
neurofibrillary tangles and amyloid plaques in rodent models of the disease (67). Because
proteins involved with many nervous system diseases are within these postsynaptic signaling
networks, the use of NMDAR antagonists or specific modulators of kinases or phosphatases
could potentially be of therapeutic benefit in a number of neurological disorders.
METHODS
Hippocampal slice stimulation
Mice were killed by cervical dislocation in accordance with Schedule 1 to the UK Animals
(Scientific Procedures) Act 1986. Hippocampal slices from 12- to 14-week-old 129S5/
SvEvBrd mice bred at the Wellcome Trust Sanger Institute were prepared as described (68)
and in supplemental data (table S17). Slices were incubated with 20 μM NMDA(3min),50
μM forskolin (15 min), wortmannin 200 nm (40 min), 10 μM phorhol 12,13-dibutyrate
(PdBu) (15 min), 10 μM SB415286 (90 min), 10 μM KN-62 (30 min), and 20 μM U0126
(40 min). All drugs were from Tocris Cookson Ltd (Bristol, UK). Postsynaptic density
fractions were prepared as described (supplemental data). For MS experiments, hippocampal
slices from the same animals were treated with NMDA or untreated, in six independent
assays, for a total of 24 mice. The Triton X-100 insoluble fraction was isolated from
NMDA-treated (20 mM NMDA for 3 min) and control mouse hippocampal slices. This
fraction (3 mg) was solubilized in 1% deoxycholate, treated with TCEP [tris(2-
carboxyethyl)phosphine] and digested with trypsin for 4 hours. Desalted peptides were
methyl-esterified for 2 hours and phosphopeptides were isolated using gallium IMAC as
described previously (7).
LC-MS/MS and MS3 analysis
Phosphopeptides were separated with a 2-hour RP gradient on a PepMap C18 column (75-
μm inner diameter × 15 cm; LC Packings). Phosphopeptides purified from control and
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NMDA-stimulated samples were analyzed using a hybrid linear ion trap–Fourier transform
ion cyclotron resonance (FTICR) mass spectrometer which was operated with a cycle of one
MS (in the FTICR cell) and three MS/MS scans and up to three neutral loss triggered MS3
scans (in the ion trap) in parallel taking less than 2 s.
All data were processed by BioWorks v3.2 (Thermo) and searched using Mascot against a
nonredundant, nonidentical mouse sequence database generated in-house. Static
modification of methyl DE and C-term and variable modification of Oxidation (M), Acetyl
(protein N-term), Phospho (STY), and Phospho PL (ST) for MS3 spectra were used for
database searching with a peptide tolerance of 0.5 Da and an MS/MS tolerance of 0.8 Da.
False discovery rates determined by Mascot decoy searches and empirical analyses of the
distributions of mass deviation and Mascot Ion Score were used to establish score and mass
accuracy filters. The mascot homology threshold was found to produce a 1% false discovery
rate (FDR) by decoy searching and as such was adopted as first-pass filter of the data.
Empirical analysis of high-quality MS2 spectra also showed 89% of these peptides fell
within a 25-ppm window of the calculated mass, and as such, this mass accuracy value was
used as an additional measure of confidence for MS2 peptide identification. Decoy
searching also revealed that the identification of MS2-MS3 pairs by chance alone was
unlikely (FDR 0%). As such, any MS2-MS3 pairs identified were accepted as true positive
identifications.
As MS data are acquired in the FTICR cell, high accuracy and continuous measurement of
the mass and intensity of phosphopeptides eluting into the mass spectrometer are achieved.
The area under each peptide peak as monitored in the MS survey chromatogram is indicative
of its abundance and comparison of peak areas for each phosphopeptide in the control and
NMDA experiments provides a quantitative measure of differential phosphopeptide
abundance based on multiple data points. Phosphopeptide identifications were performed
with MASCOT and scan numbers of approved phosphopeptide were matched to
phosphopeptide peaks in the MS survey chromatogram. Peak area calculations were made
with BioWorks version 3.2 (Thermo Fisher) using ICIS peak detection. MS data processing
and analysis are described in the supplementary methods section.
Peptide array phosphorylation assays
Jerini Phosphosite detector peptide arrays (Jerini Peptide Technologies, Gmbh) were used to
analyze 600 peptide sequences corresponding to 91 PSD proteins with the use of previously
described methods (7) and Supplemental Data. For priming arrays, additional
phosphorylated sequences and corresponding controls were included in a 300-peptide array
(table S18) probed with PKCα,CKI,ERK2,TBK1, Fyn, GSK3β, and p38α. (For protein
kinase list, see table S18.)
Overlap between sets of molecules
The statistical significance of an overlap between two sets of molecules was calculated with
the method of Pocklington et al.(15). This was used to analyze the phosphorylation of
substrate classes (and sites within functional motifs) by kinase classes. See Supplemental
Data for further details and table S19.
Convergence of kinase classes onto adjacent sites
Each site phosphorylated in the array was first classified according to the kinase class (Bas,
Pro, Ac/Ph, Other, Tyr) providing >50% of its interactions, those in which no class
predominated being classified as mixed. All pairs of adjacent sites (within 10 amino acids of
each other) were identified, and the number of pairings of each classification was counted.
Site classifications were randomly permuted 10,000 times, and the number of pairings in
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each permutation was counted. The probability ρ(m)of a pairing occurring m times was
estimated as Nm/10,000, where Nm was the number of permutations in which m pairings
were found. Values quoted in the text sum over all ρ(m) for which ρ(m) ≤ ρ(α) (i.e., the
probability of a number of pairings as or less likely than α), where α is the actual number of
pairings.
Motifs overlapping phosphorylation sites
The amino acid sequence of each substrate was randomly permuted, keeping the location of
phosphorylation sites constant. Regular expression matching was then used to count the
number of phosphorylation sites present in each type of motif. Recording the results of
10,000 such random permutations, we estimated the probability of a motif occurring m times
as Nm/10,000. For m greater (less) than the expected number occurrences, Nm is the number
of random permutations in which the motif occurred m or more (less) times. An identical
procedure was used to analyze the number of modulated peptides containing potential
phosphorylation sites within functional motifs.
Footnotes




Fig. S1. In vivo validation of peptide arrays.
Fig. S2. Phosphorylation of protein interaction domains and motifs.
Table S1. Phosphopeptide identifications by LC-MS/MS and MS3.
Table S2. Summary of phosphorylation states identified in each phosphopeptide.
Table S3. List of NMDA-modulated proteins and their functional classification.
Table S4. Analysis of glutamate receptor phosphorylation.
Table S5. NMDA-modulated proteins linked to disease.
Table S6. Known (in vivo) phosphorylation sites used in peptide arrays.
Table S7. Phosphorylation of other sites in peptide array.
Table S8. Additional phosphorylation sites in synaptic proteins.
Table S9. Protein name and functional classification of substrates represented in peptide array assays.
Table S10. Protein sequences of substrates used in peptide arrays.
Table S11. Protein kinases used in peptide arrays.
Table S12. Peptide array quantitation.
Table S13. Phosphorylation of known in vivo sites tested in peptide array.
Table S14. Phosphorylation of sequences with nondetermined phosphorylation sites.
Table S15. Phosphopeptide priming arrays.
Table S16. List of sequences tested in phosphopeptide priming arrays.
Table S17. Antibodies used in Western blot assays.
Table S18. Recombinant kinases used in peptide arrays.
Table S19. Kinase-kinase phosphorylation map of protein kinases used in peptide array assays.
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One-sentence summary: Analysis of protein phosphorylation patterns provides insight
into the organization of molecular networks at the postsynaptic density.
Editor’s Summary:
Patterning Postsynaptic Phosphorylation
The postsynaptic density of excitatory synapses in the mammalian brain—the initial site
for integration of incoming information from the presynaptic neuron—contains over a
thousand different proteins. Rather than investigating the effects of neurotransmitter
signaling on a single pathway, Coba et al. explored the functional organization of these
postsynaptic density proteins. Using a large-scale proteomic approach, they found that
stimulation of different classes of neurotransmitter receptor affected the phosphorylation
status of hundreds of phosphorylation sites in overlapping networks of postsynaptic
density proteins. Identification of a set of regulatory phosphorylation motifs enabled
them to construct a model of the molecular circuitry of the postsynaptic proteome, a
crucial step in elucidating how postsynaptic neurons process incoming information.
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NMDA stimulation of hippocampal slices. (A) NMDA-mediated changes in the
phosphorylation status of 127 proteins of the PSD (detected by MS). (B) NMDA-dependent
modulation of 9 of 23 different kinases from five groups, detected by immunoblot 3 min
after NMDAR stimulation. (C) Modulation of 7 kinases was assayed by immunoblotting
with phosphospecific antibodies of hippocampal slice extracts after NMDA stimulation.
Peak changes occurred between 3 and 5 min after stimulation, and phosphorylation returned
to the basal state after 40 min.
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Overlapping networks driven by NMDA, mGlu and dopamine receptors, and PKA and PKC.
Phosphorylation on NMDA (NR1, NR2B) and AMPA subunits (GluR1, GluR2) (10 total)
was monitored with phosphospecific antibodies after stimulation. The following receptors
were stimulated with the indicated agonists: NMDAR: NMDA (20 μM), dopamine D1–like
agonist (6-Cl-PB, 50 μM), mGluR (DHPG, 50 μM). PKA was activated directly with
forskolin (50 μM) and PKC with PdBu (10 μM). Red: increase in phosphorylation
compared to control; yellow: no change; blue: decrease.
Coba et al. Page 18










Regulatory motifs and mapping of kinase sites. (A and B) Sequences contain single (A) or
multiple (B) sites and regulatory motifs representing different phosphorylation events were
described by their substrate-kinase interactions (C to G). s, substrate. (C) Kinase divergence:
a single kinase can phosphorylate multiple independent sequences. k, kinase, P, phosphate.
(D) Kinase convergence: single site sequence phosphorylated by multiple kinases. (E)
Paired convergence: multiple site sequence with two different kinases phosphorylating each
site. (F) Paired convergence: multiple site sequence with a single kinase phosphorylating
each site. (G) Primed convergence: phosphorylation sites within 10 amino acids of each
other presenting priming effects in which the presence of phosphate on site 1 influences
phosphorylation of site 2. (H) Scheme for kinase site identification on peptide substrates.
Fifteen amino acid peptides containing a phosphorylation site and a control peptide (for
instance, in which a serine site was substituted with an alanine) were immobilized and
phosphorylated on glass slides. Representative phosphoimages of 32P-labeled arrays after
kinase reactions with PKA (triplicate samples) and six other kinases. JNK3, c-Jun N-
terminal kinase 3 Fes, c-fps/fes proto-oncogene tyrosine kinase. ROCK-II, Rho-associated
kinase 2.
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Postsynaptic phosphoproteome network. The network was constructed by linking kinases to
their respective substrates, which include other kinases. We separated the network into
groups of proteins (with a high density of links within each group and a lower density of
links between different groups) with the use of an unsupervised clustering algorithm. In the
diagram, each group was separated into two levels (one level containing kinases, the other
containing substrates) for ease of viewing. Kinases were not randomly distributed within this
clustering: One cluster was enriched with basophilic kinases (although it also contained
other kinases), another was enriched with proline-directed kinases, and so forth. Thus, the
network of phosphorylation interactions shows evidence of a broad organizational pattern
based on kinase classes, although there is cross talk. For each substrate, phosphorylation
sites were categorized into regulatory motifs (Fig. 3). Adjacent to each substrate is a
“barcode” composed of five boxes (shaded either black or white) indicating the presence
(black) or absence (white) of particular regulatory motifs within that substrate. Kinases (top)
and substrate (bottom) interactions were graphed (gray lines) and clustered with the
algorithm of Newman and Girvan (69). Functional classes of substrates are shown (colored
symbols, see key).
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Distribution of kinase types, sequence motifs, classes of proteins and hubs in phosphorylated
substrates. (A) Protein kinases were grouped by their preferred sequence specificity into five
categories: basophilic (blue), proline-directed (green), acid and phosphate-directed (red),
other (yellow), and tyrosine (purple). The number of sites phosphorylated by each kinase is
shown, with the top substrate class targeted by each kinase and the percentage of the total
number of phosphorylated sites detected. Columns indicate specific kinases (kinase), the
total number of substrate phosphorylation sites (n site), and total number of protein
substrates (n substrate) and preferred functional class of substrates (most phosphorylated
family) with the percentage of that substrate shown (% sites). (B) Proportion of (peptide
array) Ser/Thr phosphorylation events due to each kinase group (color coding as in A).
Shows percentage of all Ser/Thr phosphorylation events and of events for each functional
class of substrate. Note uneven distribution, with proline-directed kinases showing a
preference for structural and trafficking substrates. (C) Hubs or highly phosphorylated
substrates phosphorylated by 10 or more kinases. Total, number of kinases that
phosphorylate that protein. N kinase/site, number of kinases that phosphorylate the Hub site.
Coba et al. Page 21










Phosphorylation site interactions on priming arrays. (A) Interaction between
phosphorylation sites in multiple phosphorylated sequences. Peptides with two
phosphorylation sites (S1, site 1; S2, site 2) are represented (top left) and, after kinase
reaction that is specific to site 2, we measured the incorporation of 32P (black circle, top
right). Peptides synthesized with a phosphate on site 1 (white circle, lower left) are used in
the same kinase reaction and the site 2 incorporation measured (black circle, lower right).
An increase or decrease in site 2 phosphorylation is indicated by the larger or smaller black
symbol. (B) Two examples (NR1, PSD95) in which introduction of a phosphorylation site
into a sequence (S1) decreased the total phosphorylation of a second phosphorylation site
(S2). Each histogram shows the site 2 phosphorylation (% control) for peptide control (C,
corresponds to top right peptide in A) and its primed variant (P, corresponds to bottom right
peptide in A) for the representative kinase (k). (C) In contrast to (B), two examples
(Kcnab2, PDK-1) in which the introduction of a phosphorylation site into a peptide
sequence (S1) increased the total phosphorylation of a second phosphorylation site (S2). (D)
The overall effect of priming on all peptides shows that 34% had no effect, whereas 48%
were inhibitory and 18% were enhancing.
Coba et al. Page 22
Sci Signal. Author manuscript; available in PMC 2012 February 16.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
